Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
Acute Disseminated Encephalomyelitis (ADEM)-A Rare Complication of Falciparum Malaria.
Glutathione Homeostasis Disruption of Erythrocytes, but Not Glutathione Peroxidase Activity Change, Is Closely Accompanied with Neurological and Radiological Scoring of Acute CNS Inflammation.
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
Self-Efficacy as a Predictor of Self-Reported Physical, Cognitive, and Social Functioning in Multiple Sclerosis.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab.
Live-Imaging in the CNS: New Insights on Oligodendrocytes, Myelination, and their Responses to Inflammation.
[Treatment of transplantation of NT-3 gene modified olfactory ensheathing cells on experimental autoimmune encephalomyelitis in rats].
Higher macular volume in patients with MS receiving fingolimod: Positive outcome or side effect?
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians.
Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients.
Environmental factors acting during development to influence MS risk: insights from animal studies.
A new model of cuprizone-mediated demyelination/remyelination.
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
[Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis.]
[Clinical and epidemiological aspects of multiple sclerosis in the Moscow region.]
Multiple sclerosis-like neurological manifestations in a coeliac patient: nothing is as it seems.
Interferon-β-1a-induced psychosis in a patient with multiple sclerosis.

Pages